1. Home
  2. AGX vs KRYS Comparison

AGX vs KRYS Comparison

Compare AGX & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Argan Inc.

AGX

Argan Inc.

HOLD

Current Price

$701.29

Market Cap

8.6B

ML Signal

HOLD

Logo Krystal Biotech Inc.

KRYS

Krystal Biotech Inc.

HOLD

Current Price

$281.57

Market Cap

7.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AGX
KRYS
Founded
1961
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Engineering & Construction
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.6B
7.8B
IPO Year
1995
2017

Fundamental Metrics

Financial Performance
Metric
AGX
KRYS
Price
$701.29
$281.57
Analyst Decision
Buy
Strong Buy
Analyst Count
6
11
Target Price
$409.50
$297.60
AVG Volume (30 Days)
233.2K
215.1K
Earning Date
03-26-2026
05-04-2026
Dividend Yield
0.32%
N/A
EPS Growth
58.37
128.00
EPS
9.74
1.83
Revenue
$944,606,000.00
$389,130,000.00
Revenue This Year
$33.81
$38.74
Revenue Next Year
$20.97
$32.53
P/E Ratio
$71.73
$152.60
Revenue Growth
8.06
33.94
52 Week Low
$164.00
$123.03
52 Week High
$715.98
$298.30

Technical Indicators

Market Signals
Indicator
AGX
KRYS
Relative Strength Index (RSI) 72.66 61.33
Support Level $258.40 $254.53
Resistance Level N/A $293.60
Average True Range (ATR) 28.73 10.66
MACD 1.65 0.07
Stochastic Oscillator 86.11 98.66

Price Performance

Historical Comparison
AGX
KRYS

About AGX Argan Inc.

Argan Inc is a United States-based construction firm that conducts operations through its wholly-owned subsidiaries, GPS, APC, TRC, and SMC. Through GPS and APC it provides a full range of engineering, procurement, construction, commissioning, maintenance, project development and technical consulting services to the power generation market, including the renewable energy sector, for a wide range of customers, including independent power project owners, public utilities, power plant heavy equipment suppliers and other commercial firms with power requirements in the U.S., Ireland and the U.K. It operates in three segments: Power Services, Industrial Services, and Teledata, out of which Power Services derives the majority of revenue.

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

Share on Social Networks: